Literature DB >> 8778266

A prospective study on the predictive value of CSF oligoclonal bands and MRI in acute isolated neurological syndromes for subsequent progression to multiple sclerosis.

E Paolino1, E Fainardi, P Ruppi, M R Tola, V Govoni, I Casetta, V C Monetti, E Granieri, M Carreras.   

Abstract

A prospective study in patients with a clinical acute isolated brainstem or spinal cord disorder was undertaken. The aim was to evaluate the predictive value of IgG intrathecal synthesis (through the detection of oligoclonal bands in CSF) and MRI lesions at presentation, for the subsequent progression to multiple sclerosis. Forty four patients took part in this study: 22 had a brainstem disorder and 22 a spinal cord disorder. After a mean period of 26 (SD 22) months, 30 patients (68.2%) developed clinically definite multiple sclerosis. The remaining 14 patients were followed up for more than seven years. Twenty six (59.1%) patients had oligoclonal bands in CSF, with a sensitivity of 80.0%, specificity of 85.7%, and a predictive value of 92.2%. Magnetic resonance imaging showed disseminated white matter lesions in 22 patients (50.0%), with a sensitivity of 60.0%, a specificity of 71.4%, and a predictive value of 81.7%. The difference between patients with multiple sclerosis and patients without the disease was statistically significant for the findings of an IgG intrathecal synthesis (P < 0.001). It was only borderline for the MRI findings (P = 0.052). Thus the detection of an intrathecal synthesis at presentation seemed to be a better prognostic indicator of the progression to multiple sclerosis in patients affected by acute isolated brainstem or spinal cord syndromes.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8778266      PMCID: PMC486374          DOI: 10.1136/jnnp.60.5.572

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  29 in total

Review 1.  Multiple sclerosis: the blood-brain-barrier and the measurement of de novo central nervous system IgG synthesis.

Authors:  W W Tourtellotte; B I Ma
Journal:  Neurology       Date:  1978-09       Impact factor: 9.910

2.  Principles of albumin and IgG analyses in neurological disorders. III. Evaluation of IgG synthesis within the central nervous system in multiple sclerosis.

Authors:  H Link; G Tibbling
Journal:  Scand J Clin Lab Invest       Date:  1977-09       Impact factor: 1.713

3.  Electrophoretic examination of cerebrospinal fluid proteins in multiple sclerosis and other neurological diseases.

Authors:  B Vandvik; S Skrede
Journal:  Eur Neurol       Date:  1973       Impact factor: 1.710

4.  The predictive value of cerebrospinal fluid electrophoresis in 'possible' multiple sclerosis.

Authors:  D Moulin; D W Paty; G C Ebers
Journal:  Brain       Date:  1983-12       Impact factor: 13.501

5.  New diagnostic criteria for multiple sclerosis: guidelines for research protocols.

Authors:  C M Poser; D W Paty; L Scheinberg; W I McDonald; F A Davis; G C Ebers; K P Johnson; W A Sibley; D H Silberberg; W W Tourtellotte
Journal:  Ann Neurol       Date:  1983-03       Impact factor: 10.422

6.  CSF electrophoresis in one thousand patients.

Authors:  G C Ebers; D W Paty
Journal:  Can J Neurol Sci       Date:  1980-11       Impact factor: 2.104

7.  [Immunochemical estimation of IgG and albumin in cerebrospinal fluid].

Authors:  B Delpech; E Lichtblau
Journal:  Clin Chim Acta       Date:  1972-03       Impact factor: 3.786

8.  Central nervous system IgG synthesis in multiple sclerosis. Application of a new formula.

Authors:  E Schuller; H J Sagar
Journal:  Acta Neurol Scand       Date:  1983-06       Impact factor: 3.209

9.  Biochemical findings in multiple sclerosis IV. Isoelectric focusing of the CSF gamma globulins in multiple sclerosis (262 cases) and other neurological diseases (272 cases).

Authors:  P Delmotte; R Gonsette
Journal:  J Neurol       Date:  1977-04-28       Impact factor: 4.849

10.  Multiple sclerosis: measurement and validation of central nervous system IgG synthesis rate.

Authors:  W W Tourtellotte; A R Potvin; J O Fleming; K N Murthy; J Levy; K Syndulko; J H Potvin
Journal:  Neurology       Date:  1980-03       Impact factor: 9.910

View more
  12 in total

Review 1.  B-cells and humoral immunity in multiple sclerosis. Implications for therapy.

Authors:  Sangjin Oh; Cornelia Cudrici; Takahiro Ito; Horea Rus
Journal:  Immunol Res       Date:  2008       Impact factor: 2.829

Review 2.  Differentiation of multiple sclerosis subtypes: implications for treatment.

Authors:  Andreas Bitsch; Wolfgang Brück
Journal:  CNS Drugs       Date:  2002       Impact factor: 5.749

Review 3.  Disease biomarkers in multiple sclerosis: potential for use in therapeutic decision making.

Authors:  Violaine K Harris; Saud A Sadiq
Journal:  Mol Diagn Ther       Date:  2009       Impact factor: 4.074

4.  Risk of multiple sclerosis following clinically isolated syndrome: a 4-year prospective study.

Authors:  Roberto D'Alessandro; Luca Vignatelli; Alessandra Lugaresi; Elisa Baldin; Franco Granella; Maria Rosaria Tola; Susanna Malagù; Luisa Motti; Walter Neri; Massimo Galeotti; Mario Santangelo; Laila Fiorani; Enrico Montanari; Cinzia Scandellari; Maria Donata Benedetti; Maurizio Leone
Journal:  J Neurol       Date:  2013-02-03       Impact factor: 4.849

5.  Potential of a unique antibody gene signature to predict conversion to clinically definite multiple sclerosis.

Authors:  Elizabeth M Cameron; Sade Spencer; Jonathan Lazarini; Christopher T Harp; E Sally Ward; Mark Burgoon; Gregory P Owens; Michael K Racke; Jeffrey L Bennett; Elliot M Frohman; Nancy L Monson
Journal:  J Neuroimmunol       Date:  2009-07-24       Impact factor: 3.478

6.  Updates on clinically isolated syndrome and diagnostic criteria for multiple sclerosis.

Authors:  Jacqueline F Marcus; Emmanuelle L Waubant
Journal:  Neurohospitalist       Date:  2013-04

7.  Acute transverse myelitis with normal brain MRI : long-term risk of MS.

Authors:  Jui Perumal; Rana Zabad; Christina Caon; Megan MacKenzie; Alexandros Tselis; Fen Bao; Zahid Latif; Imad Zak; Robert Lisak; Omar Khan
Journal:  J Neurol       Date:  2007-12-20       Impact factor: 4.849

Review 8.  Paediatric clinically isolated syndromes: report of seven cases, differential diagnosis and literature review.

Authors:  Chiara Trabatti; Thomas Foiadelli; Maria Valentina Spartà; Chiara Gagliardone; Berardo Rinaldi; Maria Delmonte; Alessandro Lozza; Salvatore Savasta
Journal:  Childs Nerv Syst       Date:  2015-11-19       Impact factor: 1.475

9.  Evidence for the role of B cells and immunoglobulins in the pathogenesis of multiple sclerosis.

Authors:  Bharath Wootla; Aleksandar Denic; B Mark Keegan; Jeffrey L Winters; David Astapenko; Arthur E Warrington; Allan J Bieber; Moses Rodriguez
Journal:  Neurol Res Int       Date:  2011-09-22

10.  Is multiple sclerosis an autoimmune disease?

Authors:  Bharath Wootla; Makoto Eriguchi; Moses Rodriguez
Journal:  Autoimmune Dis       Date:  2012-05-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.